OOIR: Observatory of International Research

Papers

(The H4-Index of Current Opinion in Pharmacology is 25. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)

Article	Citations
The molecular link between oxidative stress, insulin resistance, and type 2 diabetes: A target for new therapies against cardiovascular diseases	64
Dyslipidemia and diabetes mellitus: Role of lipoprotein species and interrelated pathways of lipid metabolism in diabetes mellitus	63
Nanotechnology in pulmonary medicine	55
Gestational diabetes: Implications for fetal growth, intervention timing, and treatment options	48
Prospects for COPD treatment	47
Targeting fibroblast-like synoviocytes in rheumatoid arthritis	45
The regulatory roles of dietary fibers on host health via gut microbiota-derived short chain fatty acids	42
Targeting B cells for inflammatory bowel disease treatment: back to the future	42
Transforming targeted cancer therapy with PROTACs: A forward-looking perspective	41
Current advances in the treatment of systemic sclerosis	41
Antihypertensive effect of soybean bioactive peptides: A review	36
A review of emerging neuroprotective and neuroregenerative therapies in traumatic spinal cord injury	35
Role of HSV-1 in Alzheimer's disease pathogenesis: A challenge for novel preventive/therapeutic strategies	34
Role of O-linked N-acetylglucosamine (O-GlcNAc) modification of proteins in diabetic cardiovascular complications	32
Astrocytes as cellular mediators of cue reactivity in addiction	32
The role of the liver in the modulation of glucose and insulin in non alcoholic fatty liver disease and type 2 diabetes	32
Glutamate receptors and metaplasticity in addiction	31
Circadian control of human cardiovascular function	30
Emerging mutations in the SARS-CoV-2 variants and their role in antibody escape to small molecule-based therapeutic resistance	29
Monitoring vedolizumab and ustekinumab drug levels in patients with inflammatory bowel disease: hype or hope?	28
Paeoniflorin is a promising natural monomer for neurodegenerative diseases via modulation of Ca2+ and ROS homeostasis	27
N-methyl-d-aspartate receptor function in neuronal and synaptic development and signaling	27
Treatment of early rheumatoid arthritis: Methotrexate and beyond	26
Treatments for COVID-19: Lessons from 2020 and new therapeutic options	25
Exercise as a drug for glucose management and prevention in type 2 diabetes mellitus	25

Alpha1-antitrypsin deficiency: New therapies on the horizon	25
Chronotherapy of cardiac and vascular disease: timing medications to circadian rhythms to optimize treatment effects and outcomes	25
Does probiotics work for bacterial vaginosis and vulvovaginal candidiasis	25